In Silico Prediction and In Vitro Assessment of Multifunctional Properties of Postbiotics Obtained From Two Probiotic Bacteria
- 2019-07-06
- Probiotics and Antimicrobial Proteins 12(2)
- J. E. Aguilar-Toalá
- F. Hall
- U. Urbizo-Reyes
- H. García
- B. Vallejo‐Cordoba
- A. F. González-Córdova
- A. Hernández-Mendoza
- A. Liceaga
- PubMed: 31280464
- DOI: 10.1007/s12602-019-09568-z
Abstract
In this study, a global metabolite profile using Raman spectroscopy analysis was obtained in order to predict, by an in silico prediction of activity spectra for substance approach, the bioactivities of the intracellular content (IC) and cell wall (CW) fractions obtained from Lactobacillus casei CRL 431 and Bacillus coagulans GBI-30 strains. Additionally, multifunctional in vitro bioactivity of IC and CW fractions was also assessed. The metabolite profile revealed a variety of compounds (fatty acids, amino acids, coenzyme, protein, amino sugars), with significant probable activities (Pa > 0.7) as immune-stimulant, anti-inflammatory, neuroprotective, antiproliferative, immunomodulator, and antineoplastic, among others. Moreover, in vitro assays exhibited that both IC and CW fractions presented angiotensin-converting enzyme-inhibitory (> 90%), chelating (> 79%), and antioxidant (ca. 22-57 cellular antioxidant activity units) activities. Our findings based on in silico and in vitro analyses suggest that L. casei CRL 431 and B. coagulans GBI-30 strains appear to be promising sources of postbiotics and may impart health benefits by their multifunctional properties.
Keywords: In silico prediction; Lactobacillus; Multifunctional bioactivity; Postbiotics.
Research Insights
Supplement | Health Outcome | Effect Type | Effect Size |
---|---|---|---|
Bacillus coagulans GBI-30, 6086 | Enhanced Chelation Ability | Beneficial | Large |
Bacillus coagulans GBI-30, 6086 | Enhanced Immune Function | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Improved Neuroprotection | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Increased Antioxidant Activity | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Increased Immune Function | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Reduced Angiotensin I-Converting Enzyme Activity | Beneficial | Large |
Bacillus coagulans GBI-30, 6086 | Reduced Cancer Cell Proliferation | Beneficial | Moderate |
Bacillus coagulans GBI-30, 6086 | Reduced Inflammation | Beneficial | Moderate |